# Sugammadex and Cognitive Function

> **NCT02419352** · NA · COMPLETED · sponsor: **Attikon Hospital** · enrollment: 160 (actual)

## Conditions studied

- Post Operative Cognitive Dysfunction

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Neostigmine/atropine

## Key facts

- **NCT ID:** NCT02419352
- **Lead sponsor:** Attikon Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2020-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02419352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02419352, "Sugammadex and Cognitive Function". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02419352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*